Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2013; 5(11): 426-433
Published online Nov 26, 2013. doi: 10.4330/wjc.v5.i11.426
Published online Nov 26, 2013. doi: 10.4330/wjc.v5.i11.426
Group I | Group II | P value | |
(n = 63) | (n = 76) | ||
Age | 60 ± 1 | 59 ± 1 | NS |
Men/women | 40/23 | 46/30 | NS |
Body mass index (kg/m2) | 24.6 ± 0.3 | 24.2 ± 0.3 | NS |
Coronary risk factors | |||
Smoking (%) | 22 (35) | 19 (25) | NS |
Hypertension (%) | 29 (46) | 29 (38) | NS |
Hypercholesterolemia (%) | 23 (37) | 30 (39) | NS |
Diabetes mellitus (%) | 9 (14) | 6 (8) | NS |
Medications | |||
Statins (%) | 11 (17) | 13 (17) | NS |
ACI and/or ARB (%) | 8 (13) | 11 (14) | NS |
LV ejection fraction (%) | 70 ± 1 | 71 ± 1 | NS |
- Citation: Teragawa H, Mitsuba N, Ishibashi K, Kurisu S, Kihara Y. Positive influence of aspirin on coronary endothelial function: Importance of the dose. World J Cardiol 2013; 5(11): 426-433
- URL: https://www.wjgnet.com/1949-8462/full/v5/i11/426.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i11.426